James Christensen
Director/Board Member bij BOUNDLESS BIO, INC.
Vermogen: - $ op 31-03-2024
Profiel
Momenteel bekleedt James G. Christensen de functie van Chief Scientific Officer & Executive VP bij Mirati Therapeutics, Inc. Hij zit ook in de raad van bestuur van BCTG Acquisition Corp. In het verleden was hij Senior Director-Oncology Precision Medicine bij Pfizer Inc. Dr. Christensen behaalde een doctoraat aan de North Carolina State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 28-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van James Christensen
| Bedrijven | Functie | Begin |
|---|---|---|
| BOUNDLESS BIO, INC. | Director/Board Member | 02-10-2023 |
Eerdere bekende functies van James Christensen
| Bedrijven | Functie | Einde |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 23-01-2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2013 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | - |
Opleiding van James Christensen
| North Carolina State University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance BCTG Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in May 2020 and is headquartered in San Diego, CA. | Finance |
